Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
NINGBO INNO PHARMCHEM CO.,LTD. is pleased to provide insights into the scientific advancements shaping the future of pain management. The development of PZM21 exemplifies how cutting-edge research can lead to innovative solutions for persistent health challenges. In an era where the dangers of opioid addiction are widely recognized, the quest for effective and safe pain relief has intensified, with PZM21 emerging as a promising candidate.
The journey to create PZM21 involved a sophisticated, multi-faceted approach to drug discovery. Scientists aimed to replicate the powerful pain-relieving capabilities of opioids like morphine while systematically eliminating their most problematic side effects, namely addiction, respiratory depression, and constipation. This endeavor required a deep understanding of molecular pharmacology and the ability to design compounds with highly specific actions. The result is a novel pain relief compound that targets pain pathways directly, setting it apart from traditional opioids and contributing to the development of safer opioid analgesics.
The core of PZM21's innovation lies in its mechanism of action. Researchers focused on creating a molecule that could activate the desired pain-relief pathways without triggering the neurochemical responses associated with euphoria and addiction. This selective activation ensures effective analgesia, fulfilling the critical need for pain management without addiction. The development process leveraged advanced computational tools to screen millions of potential compounds, followed by meticulous chemical synthesis and extensive preclinical testing. This thorough approach highlights the rigorous nature of pharmaceutical research breakthroughs.
PZM21's potential extends beyond just treating acute pain; it represents a significant step towards developing truly non-addictive pain management solutions. By offering a morphine substitute with less risk, it provides a safer alternative for patients who require potent pain relief. NINGBO INNO PHARMCHEM CO.,LTD. believes that continued investment in such scientific endeavors is crucial for addressing the widespread challenges of pain and addiction, ultimately improving patient care and public health.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
